Health Care Services

Novo Integrated Sciences

Novo Integrated Sciences released FY2024 Q4 earnings on December 18, 2024 (EST) with actual revenue of 3,080,696 USD and EPS of 0.2623

Novo Integrated Sciences released FY2024 Annual Earnings on December 18, 2024 (EST), with actual revenue of 13,294,357 USD and EPS of -0.8965

Novo Integrated Sciences Board Conducts Strategic Review to Increase Maximum Amount Under Stock Repurchase Plan

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Cigna

BrightSpring Health Services - Unit

Labcorp

Quest Diagnostics

Hims & Hers Health

BrightSpring Health Services

Chemed

Option Care Health

GeneDx

CorVel

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap